ARLINGTON, Va., Sept. 23 /PRNewswire/ -- BioInformatics, LLC (http://www.gene2drug.com), the leading market research and consulting firm serving the life science industry, announces the publication of its latest report, "Protein Research: Strategies for Marketing to Chemists and Biologists." A joint effort between BioInformatics, LLC and the American Chemical Society, the report is designed to help suppliers of protein research tools and technologies identify workflow patterns and applications, discover unmet technology needs and explore instrument-purchasing drivers among biologists and chemists.
"A more in-depth understanding of the needs of scientists studying protein research is of growing importance as the field becomes more complex and funding sources become harder to obtain," observed Dr. Tamara Zemlo, Director of Syndicated Research and Analysis for BioInformatics, LLC. "Furthermore, we have identified significant overlap in how biologists and chemists use the equipment, thereby allowing companies to streamline the marketing effort to appeal to scientists in both disciplines."
By exploring the usage and purchase drivers behind both the higher dollar mass spectrometry and HPLC instrumentation, and the less expensive electrophoresis equipment products, manufacturers and scientists alike can understand what, in addition to cost, is influencing purchase decisions. This study explores how these preferences play out differently (and the same) between biologists and chemists.
Designed to help identify key areas of investigation among protein researchers, perceived bottlenecks, potential budgetary implications and customer perceptions of leading providers of instrumentation, this benchmarking study allows suppliers to gain keen insight into the evolving needs of their protein research customers, while more clearly defining certain industry-wide best practices. The information in this report can be used to provide direction as to how suppliers can increase sales volume through innovative product offerings and continue to better meet the needs of current users.
"One of the greatest areas of concern is an ability to meet the higher demand for increased throughput," Zemlo noted. Contained within the report are "Scorecards" for each of the instruments studied. These scorecards provide at-a-glance information as to how biologists and chemists use their protein research tools, what features are most important to them and what kind of purchase criteria they use for choosing vendors.
"Protein Research: Strategies for Marketing to Chemists and Biologists" is based on responses to a 53-question online survey conducted by BioInformatics, LLC. 275 chemists and 443 biologists from North America completed an online survey fielded between June 25 and August 1, 2008. Plan to attend a free webinar to discuss this report on Wednesday, October 22 at 1pm EDT. To register for your virtual seat at the webinar, email email@example.com. For a complimentary Executive Summary of this report, please visit http://www.gene2drug.com/report/197/
ABOUT BIOINFORMATICS, LLC
BioInformatics, LLC is the premier research and advisory firm serving
the life science industry. By leveraging our professional social network of
more than 38,000 biomedical researchers, we have supported more than 300
companies and provided insights that lead to better business decisions. Our
assignments include assessing the size and attractiveness of markets,
optimizing product configurations and pricing, validating corporate
acquisitions, measuring customer loyalty, and evaluating brand strength and
For more information, please contact:
Director of Communications
2111 Wilson Blvd., Suite 250
Arlington, VA 22201
703.778.3080 x13 (phone)
|SOURCE BioInformatics, LLC|
Copyright©2008 PR Newswire.
All rights reserved